A vast majority (>95%) of late-onset Alzheimer’s disease(LOAD) patients develop cognitive dementia that was not due to mutationsin familial genes (amyloid precursor protein (APP) or presenilin-1or −2 (PS1 or PS2)), hinting at factors other than geneticsexacerbating or promoting the disease. The gene discussed is APP; the disease is Alzheimer disease.